Tibet Duo Rui Pharmaceutical Bilan de santé
Santé financière contrôle des critères 3/6
Tibet Duo Rui Pharmaceutical has a total shareholder equity of CN¥766.1M and total debt of CN¥236.7M, which brings its debt-to-equity ratio to 30.9%. Its total assets and total liabilities are CN¥1.1B and CN¥303.9M respectively.
Informations clés
30.9%
Ratio d'endettement
CN¥236.69m
Dette
| Ratio de couverture des intérêts | n/a |
| Argent liquide | CN¥396.93m |
| Fonds propres | CN¥766.15m |
| Total du passif | CN¥303.86m |
| Total des actifs | CN¥1.07b |
Mises à jour récentes de la santé financière
Pas de mise à jour
Recent updates
What Tibet Duo Rui Pharmaceutical Co., Ltd.'s (SZSE:301075) 41% Share Price Gain Is Not Telling You
Oct 09
Tibet Duo Rui Pharmaceutical's (SZSE:301075) Solid Earnings May Rest On Weak Foundations
May 01Tibet Duo Rui Pharmaceutical Co.,Ltd. (SZSE:301075) Stock Rockets 44% As Investors Are Less Pessimistic Than Expected
Mar 08Analyse de la situation financière
Passif à court terme: 301075's short term assets (CN¥615.3M) exceed its short term liabilities (CN¥133.6M).
Passif à long terme: 301075's short term assets (CN¥615.3M) exceed its long term liabilities (CN¥170.2M).
Historique et analyse du ratio d'endettement
Niveau d'endettement: 301075 has more cash than its total debt.
Réduire la dette: 301075's debt to equity ratio has increased from 20% to 30.9% over the past 5 years.
Couverture de la dette: 301075's operating cash flow is negative, therefore debt is not well covered.
Couverture des intérêts: Insufficient data to determine if 301075's interest payments on its debt are well covered by EBIT.